Home›People›David Scheer
DS

David Scheer

Executive officer and director at Adela

ExecutiveDirectorPublic company
Updated Nov 8, 2026·Latest SEC filing Oct 19, 2026·Suggest an edit

About David Scheer

David Scheer is an executive officer and director at Adela, which makes blood tests for cancer monitoring and early detection.

Experience

This experience comes from official bios, from David Scheer's profile and from SEC filings. For roles taken from filings, the years are when the filings name David Scheer in the role, so the role may have started earlier or lasted longer.

CureTrust Current
Member of the Board of Advisors
2026 – Present
Kembi Therapeutics Current
Member, Board of Directors
2025 – Present
Ladder Bio Inc. Current
Member Board of Directors
2025 – Present
Apriligen, Inc. Current
Chairman of the Board of Directors
2024 – Present
Adela, Inc. Current
Chairman of Adela's Board of Directors
Executive Officer
2021 – Present · Foster City, CA
Adela's blood tests help clinicians detect recurrence and drug developers study treatment response.
Refactor Health Current
Chairman Of The Board
2020 – Present
Flourish Biologics (formerly BiologicsMD) Current
Chairman of the Board
2020 – Present
Scheer & Company, Inc. Current
President
1981 – Present
OrphAI Therapeutics
Chairman of the Board
2023 – 2025
Revelar Biotherapeutics
Chairman Of The Board Of Directors
2021 – 2022
Achillion Pharmaceuticals Inc.
Chairman, Board of Directors
2006 – 2020 · Public company (ACHN)
Achilion Pharmaceuticals (acquired by Alexion)
Director, Chair of the Board
1998 – 2020
ArRETT Neuroscience
Chairman of the Board of Directors
2015 – 2018
Axerion Therapeutics, now ReNetX Bio
Chairman, Board of Directors
2009 – 2017
Aegerion Pharmaceuticals, Inc.
Director
2010 – 2016 · Public company (AEGR)
Aegerion Pharmaceuticals/now Amryt
Chairman, Board of Directors
2004 – 2016
Tengion Inc.
Director
2010 – 2012 · Public company (TNGN)
Esperion Therapeutics
Chairman of the Board of Directors
1998 – 2003
OraPharma Inc. (acquired by JNJ)
Member, Board of Directors
1996 – 2003
ViroPharma, Inc.
Member, Board of Directors
1994 – 1997

Key Colleagues at Startups

The people David Scheer works with at each company, as listed on that company's latest Form D.

Adela, Inc. · Form D, Oct 19, 2026
LM
Lindsay Mateo
Chief Executive Officer and director
DB
David Bonita
Director
PB
Paul Brown
Director
DC
Daniel Diniz De Carvalho
Executive officer
AH
Anne-Renee Hartman
Co-Founder and Chief Medical Officer
Maneesh Jain
Maneesh Jain
Director
AW
Alan Williams
Executive officer
AK

Sources

  1. SECAdela, Inc. Form D, filed Oct 19, 2026
  2. SECForms 3, 4 and 5 filed by David Scheer (SEC filer 1378585)
  3. P1Adela financing and leadership release
  4. P2Tengion filing passage
  5. P3Aegerion filing passage